Lv1
50 积分 2025-06-24 加入
Novel Cardiometabolic Medications in the Cardiovascular-Kidney-Metabolic Syndrome Era
4个月前
已完结
Addressing the “Nitric Oxide Crisis” in Cardiovascular–Kidney–Metabolic Syndrome: Therapeutic Potential of the Inorganic Nitrate–Nitrite–NO Pathway
4个月前
已完结
Sodium Glucose Cotransporter 2 Inhibitors Across the Spectrum of Cardiovascular Kidney Metabolic Syndrome
4个月前
已关闭
Established and Emerging Therapies for Cardiovascular-Kidney-Metabolic Syndrome: Harnessing the Benefits of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and Beyond
4个月前
已完结
Novel therapeutic targets for cardiorenal syndrome
5个月前
已完结
Evaluation of Kidney Function Throughout the Heart Failure Trajectory – A Position Statement from the Heart Failure Association of the European Society of Cardiology
6个月前
已完结
Cardiorenal Syndrome: New Pathways and Novel Biomarkers
6个月前
已完结
Roles of microRNAs in cardiorenal syndrome
6个月前
已完结
Biomarkers in Cardiorenal Syndrome: Focus on Type 1
6个月前
已关闭
Uremic Toxins and Cardiovascular System
6个月前
已关闭
皖公网安备34019202002308
